Thorac Cardiovasc Surg 2017; 65(S 01): S1-S110
DOI: 10.1055/s-0037-1598829
Oral Presentations
Monday, February 13th, 2017
DHTHG: Terminal Heart and Lung Failure - LVAD: Implantation Techniques
Georg Thieme Verlag KG Stuttgart · New York

Minimal-Invasive versus Sternotomy for LVAD Destination Therapy in Elective Patients

S. Klotz
1   Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Herz- und thorakale Gefäßchirurgie, Lübeck, Germany
,
S. Bucsky
1   Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Herz- und thorakale Gefäßchirurgie, Lübeck, Germany
,
S. Radzewitz
1   Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Herz- und thorakale Gefäßchirurgie, Lübeck, Germany
,
A. Karluss
1   Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Herz- und thorakale Gefäßchirurgie, Lübeck, Germany
,
H.H. Sievers
1   Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Klinik für Herz- und thorakale Gefäßchirurgie, Lübeck, Germany
› Author Affiliations
Further Information

Publication History

Publication Date:
03 February 2017 (online)

Objectives: LVAD as Destination Therapy (DT) is an acceptable strategy for non-transplantable end-stage heart failure patients. However, it is not yet clear if the minimal-invasive implant technique has advantages to the conventional technique via sternotomy. Especially in the older and sicker destination therapy population with higher frailty the need for a less invasive operation is preexisting. In this study we compare the minimal-invasive with the conventional LVAD implant technique in destination patients.

Methods: In 39 patients implantation of the HVAD-LVAD (HeartWare, Framingham, FL) was performed either via median sternotomy (MST, 21 pts.) or via minimal-invasive technique via anterolateral thoracotomy and partial L-shape sternotomy (MIC, 18 pts.). All operations were performed beating heart with the use of the extracorporeal circulation (ECC) or completely off-pump.

All operations were performed electively. Patients with an INTERMACS level of 1 or 2 were excluded from this study.

Results: The Table shows the preoperative risk profile. Age, gender, EuroScore, previous sternotomy and INTERMACS level were identical between the groups. While the average operation time was similar (212 ± 31 vs. 193 ± 63 minute, p = 0.244; MIC vs. MST); the time of ECC could be reduced with the MIC technique significantly (19 ± 25 vs. 83 ± 33 minute, p < 0.0001). In addition 27.8% of the MIC implants were performed completely off-pump. This might the reasons for trends toward postoperative reduction on ICU stay (6.4 ± 9.4 vs. 9.4 ± 13.9 days, p = 0.437), rate of reintubation (12.5 vs. 19.0%, p = 0.472) and rethoracotomies (9.1 vs. 31.6%, p = 0.197).

Conclusion: The minimal-invasive LVAD-Implant technique reduced the time of the ECC significantly. This might lead to shorter ICU stay with reduced morbidity. Adverse event due to the MIC technique were not observed. Larger numbers are needed to gain significant benefits in long-term survival. However, especially in the older DT population the MIC technique has the advantage for faster recovery after LVAD implantation.

Table

Preoperative demographics

MIC

MST

p Value

Age, years

65.6 ± 6.8

67.5 ± 5.7

0.359

Gender, male

88.9%

81.0%

0.667

Previous cardiac operation

44.4%

28.6%

0.337

INTERMACS level

4.3 ± 1.1

3.6 ± 1.2

0.058

EuroScore I

9.7 ± 2.7

11.1 ± 3.6

0.0166

Ischemic cardiomyopathy

66.7%

81.0%

0.465